Advertisement

Antimicrobial susceptibilities of Campylobacter jejuni isolates from hospitalized children in Athens, Greece, collected during 2004–2005

  • Eleni Papavasileiou
  • Aliki Voyatzi
  • Konstantina Papavasileiou
  • Antonia Makri
  • Ioanna Andrianopoulou
  • Stylianos ChatzipanagiotouEmail author
Letter to the Editor

Abstract

A total of 170 Campylobacter jejuni strains isolated from the stool of children with clinical gastroenteritis, aged from 3 months to 14 years, were collected during a two-year period (2004–2005). From the 170 strains 30% were resistant to ciprofloxacin (MIC ≥4 μg/ml), 55% to tetracycline (MIC > 8 μg/ml), 13% to clindamycin (MIC ≥8 μg/ml), 4% to ampicillin (MIC > 16 μg/ml), 6% to erythromycin (MIC ≥8 μg/ml), 4% to coamoxiclav (MIC ≥16/8 μg/ml) and 0% to gentamicin. Compared to previous reports from Greece, the antimicrobial resistance rates to erythromycin, ampicillin and coamoxiclav remain low, while they are still high for tetracycline and ciprofloxacin. Considering similar reports from many other countries and the high incidence of Campylobacter gastroenteritis worldwide, the value of ciprofloxacin as a first choice drug␣in the empiric treatment of the infection is questionable.

Keywords

Antimicrobial susceptibility; Campylobacter jejuni; Children gastroenteritis; Greece 

References

  1. 1.
    Gaunt PN, Piddock LJV 1996 Ciprofloxacin resistant Campylobacter spp. in humans: An epidemiological and laboratory study. J Antimicrob Chemother 37: 747–57CrossRefPubMedGoogle Scholar
  2. 2.
    Chatzipanagiotou S, Papavasileiou E, Lakumenta A et al. 2002 Antimicrobial susceptibility patterns of Campylobacter jejuni strains isolated from hospitalized children in Athens, Greece. J Antimicrob Chemother 49: 803–05CrossRefPubMedGoogle Scholar
  3. 3.
    Wagner J, Jabbusch M, Eisenblatter M, Hahn H, Wendt C, Ignatius R. 2003 Susceptibilities of Campylobacter jejuni isolates from Germany to ciprofloxacin, moxifloxacin, erythromycin, clindamycin, and tetracycline. Antimicrob Agents Chemother 47: 2358–361CrossRefPubMedGoogle Scholar
  4. 4.
    Hakanen AJ, Lehtopolku M, Siitonen A, Huovinen P, Kotilainen P 2003 Multidrug resistance in Campylobacter jejuni strains collected from Finnish patients during 1995–000. J Antimicrob Chemother 52: 1035–039CrossRefPubMedGoogle Scholar
  5. 5.
    Garcia-Campos JA, Alarcon T, Domingo D, Menendez-Rivas M, Lopez-Brea M. 2003 Susceptibility of Campylobacter jejuni clinical isolates from children to eight antibiotics. Rev Esp Quimioter 16: 216–20PubMedGoogle Scholar
  6. 6.
    Gaundreau C, Gilbert H. 2003 Antimicrobial resistance of Campylobacter jejuni subsp. jejuni isolated from humans in 1998 to 2001 in Montreal, Canada. Antimicrob Agents Chemother 47: 2017–019Google Scholar

Copyright information

© Springer Science+Business Media B.V. 2006

Authors and Affiliations

  • Eleni Papavasileiou
    • 1
  • Aliki Voyatzi
    • 1
  • Konstantina Papavasileiou
    • 1
  • Antonia Makri
    • 1
  • Ioanna Andrianopoulou
    • 1
  • Stylianos Chatzipanagiotou
    • 2
    Email author
  1. 1.Department of Clinical MicrobiologyPenteli Children HospitalAthensGreece
  2. 2.Department of Clinical MicrobiologyAthens Medical School — Aeginition HospitalAthensGreece

Personalised recommendations